WithdrawnNot Applicable

Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis

Stopped: No participants enrolled

United States0Started 2022-03-31

Plain-language summary

This study proposes to examine the relationship between the development of impaired glucose tolerance, the phenotype of CFLD, and risk of liver fibrosis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men and women ≥ 18 with CF and one of the following: * Normal OGTT * Elevated OGTT * Known CFRD Exclusion Criteria: * Men and women without CF

What they're measuring

Assess Phenotype of CFLD

Timeframe: Visit 1, Day 1

Assess Value of Complete Blood Count of CFLD

Timeframe: Visit 1, Day 1

Assess Hepatic Function of CFLD

Timeframe: Visit 1, Day 1

Assess Oral Glucose of CFLD

Timeframe: Visit 1, Day 1

Assess CFLD via abdominal imaging

Timeframe: Visit 1, Day 1

Trial details

NCT IDNCT05229640

SponsorDartmouth-Hitchcock Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06

View on ClinicalTrials.gov More CF - Cystic Fibrosis trials